Caenorhabditis elegans as a valuable model for the study of anthelmintic pharmacodynamics and drug-drug interactions: The case of ivermectin and eprinomectin
Caenorhabditis elegans is a free-living nematode that has been validated for anthelmintic drug screening. However, this model has not been used to address anthelmintic dose-response-time and drug-drug interactions through matrix array methodology. Eprinomectin (EPM) and Ivermectin (IVM) are macrocyc...
Main Authors: | Gonzalo Suárez, Ignacio Alcántara, Gustavo Salinas |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.984905/full |
Similar Items
-
Аntiparasitic complex of Ivermectin for treatment of herd horses at gastrointestinal Nematodosis
by: М. В. Musaev, et al.
Published: (2020-06-01) -
Evaluation of trypanocidal and anthelmintic efficacy of an Isometamidium – Ivermectin association in bovine
by: Gustavo López-Valencia, et al.
Published: (2021-04-01) -
A phenotypic screen of the Global Health Priority Box identifies an insecticide with anthelmintic activity
by: Harrison T. Shanley, et al.
Published: (2024-03-01) -
Pharmacokinetics of tenvermectin in swine, a novel antiparasitic drug candidate—comparison with ivermectin
by: Guiyu Li, et al.
Published: (2023-05-01) -
Outcome of Ivermectin in Cancer Treatment: An Experience in Loja-Ecuador
by: Yuliana Jiménez-Gaona, et al.
Published: (2023-02-01)